$PPCB
Propanc Biopharma Inc

2015 Q1 Form 10-Q Financial Statement

#000114420415009533 Filed on February 17, 2015

View on sec.gov

Income Statement

Concept 2015 Q1 2014 Q4 2014 Q2
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $510.0K $250.0K $110.0K
YoY Change 410.0% 8.7% -38.89%
% of Gross Profit
Research & Development $9.475K $2.443K $10.00K
YoY Change 0.0%
% of Gross Profit
Depreciation & Amortization $0.00 $0.00 $0.00
YoY Change
% of Gross Profit
Operating Expenses $516.6K $249.4K $120.0K
YoY Change 395.2% 10.64% -36.84%
Operating Profit -$516.6K -$249.4K
YoY Change 395.2% 10.64%
Interest Expense $199.3K $100.2K -$90.00K
YoY Change 901.39% 395.31% 200.0%
% of Operating Profit
Other Income/Expense, Net $62.32K -$178.5K
YoY Change 66.4% -187.75%
Pretax Income -$454.3K -$427.9K -$220.0K
YoY Change 579.35% 1840.5% 0.0%
Income Tax $0.00 -$82.44K $0.00
% Of Pretax Income
Net Earnings -$454.3K -$345.5K -$220.0K
YoY Change 579.35% -1408.68% 0.0%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$281.4M $415.3M -$374.1M
COMMON SHARES
Basic Shares Outstanding 191.7M shares 90.96M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2015 Q1 2014 Q4 2014 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $170.0K $10.00K $90.00K
YoY Change
Cash & Equivalents $14.59K $87.80K
Short-Term Investments
Other Short-Term Assets $130.0K $40.00K $30.00K
YoY Change 300.0%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $308.8K $52.94K $113.7K
YoY Change 429.4%
LONG-TERM ASSETS
Property, Plant & Equipment $808.00 $0.00
YoY Change -100.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $808.00 $0.00 $0.00
YoY Change -100.0%
TOTAL ASSETS
Total Short-Term Assets $308.8K $52.94K $113.7K
Total Long-Term Assets $808.00 $0.00 $0.00
Total Assets $309.6K $52.94K $113.7K
YoY Change 429.4% 6410.88%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $291.0K $88.09K $332.6K
YoY Change -11.81% -71.58% 22.0%
Accrued Expenses $440.0K $280.0K $490.0K
YoY Change 2.33% -24.32% 63.33%
Deferred Revenue
YoY Change
Short-Term Debt $1.250M $951.4K $0.00
YoY Change 443.48% 494.64% -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.161M $1.930M $1.522M
YoY Change 84.67% 82.09% 92.67%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $2.161M $1.930M $1.522M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $2.160M $1.930M $1.520M
YoY Change 84.62% 82.08% 92.41%
SHAREHOLDERS EQUITY
Retained Earnings -$19.14M $18.68M -$17.55M
YoY Change
Common Stock $332.8K $130.8K $72.69K
YoY Change 2.91%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$1.851M -$1.877M -$1.408M
YoY Change
Total Liabilities & Shareholders Equity $309.6K $52.94K $113.7K
YoY Change 429.4% 6410.88%

Cashflow Statement

Concept 2015 Q1 2014 Q4 2014 Q2
OPERATING ACTIVITIES
Net Income -$454.3K -$345.5K -$220.0K
YoY Change 579.35% -1408.68% 0.0%
Depreciation, Depletion And Amortization $0.00 $0.00 $0.00
YoY Change
Cash From Operating Activities -$430.0K -$170.0K -$90.00K
YoY Change 975.0% 750.0% 200.0%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 580.0K 80.00K 170.0K
YoY Change 1060.0% -500.0% 466.67%
NET CHANGE
Cash From Operating Activities -430.0K -170.0K -90.00K
Cash From Investing Activities 0.000 0.000
Cash From Financing Activities 580.0K 80.00K 170.0K
Net Change In Cash 150.0K -90.00K 80.00K
YoY Change 1400.0% 125.0%
FREE CASH FLOW
Cash From Operating Activities -$430.0K -$170.0K -$90.00K
Capital Expenditures $0.00 $0.00
Free Cash Flow -$430.0K -$170.0K
YoY Change 975.0% 750.0%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2014Q4 us-gaap Assets
Assets
52940 USD
CY2014Q2 us-gaap Assets
Assets
113745 USD
CY2014Q4 us-gaap Value Added Tax Receivable
ValueAddedTaxReceivable
2044 USD
CY2014Q2 us-gaap Value Added Tax Receivable
ValueAddedTaxReceivable
946 USD
CY2014Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
36308 USD
CY2014Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
88092 USD
CY2014Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
25000 USD
CY2014Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
332564 USD
CY2014Q4 us-gaap Cash
Cash
14588 USD
CY2014Q2 us-gaap Cash
Cash
87799 USD
CY2014Q4 us-gaap Assets Current
AssetsCurrent
52940 USD
CY2014Q2 us-gaap Assets Current
AssetsCurrent
113745 USD
CY2014Q4 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
0 USD
CY2014Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
422326 USD
CY2014Q4 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
453480 USD
CY2014Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
16753398 USD
CY2014Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-84726 USD
CY2013Q4 us-gaap Royalty Revenue
RoyaltyRevenue
0 USD
us-gaap Royalty Revenue
RoyaltyRevenue
0 USD
CY2014Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
244431 USD
CY2014Q2 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
17440 USD
CY2014Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
223841 USD
CY2014Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
951422 USD
CY2014Q2 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
60350 USD
CY2014Q2 ppch Loans From Related Party
LoansFromRelatedParty
161975 USD
CY2014Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
62827 USD
CY2014Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1522059 USD
CY2014Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2014Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2014Q2 us-gaap Common Stock Value
CommonStockValue
72685 USD
CY2014Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
16374781 USD
CY2014Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-302863 USD
CY2014Q2 us-gaap Development Stage Enterprise Deficit Accumulated During Development Stage
DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage
17552917 USD
CY2014Q2 us-gaap Stockholders Equity
StockholdersEquity
-1408314 USD
CY2014Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
113745 USD
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
-1877249 USD
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
52940 USD
CY2014Q4 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-157655 USD
CY2013Q4 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-3989 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-1211219 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-593563 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
218137 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
15168 USD
CY2013Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
203402 USD
CY2013Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-48451 USD
CY2014Q4 us-gaap Net Income Loss
NetIncomeLoss
-345479 USD
CY2013Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-22052 USD
CY2014Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-82440 USD
CY2014Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-427919 USD
CY2013Q4 us-gaap Net Income Loss
NetIncomeLoss
26399 USD
CY2014Q4 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
103320 USD
CY2013Q4 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
56099 USD
CY2014Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-242159 USD
CY2013Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
82498 USD
CY2014Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.00
CY2013Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.00
CY2014Q4 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
95007061 shares
CY2013Q4 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
72385909 shares
us-gaap Gain Loss On Repurchase Of Debt Instrument
GainLossOnRepurchaseOfDebtInstrument
34884 USD
us-gaap Gain Loss On Repurchase Of Debt Instrument
GainLossOnRepurchaseOfDebtInstrument
0 USD
CY2014Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
500000 shares
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
10000000000 shares
CY2014Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
10000000000 shares
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
130774585 shares
CY2014Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
72684767 shares
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
528496 USD
CY2014Q4 us-gaap Occupancy Costs
OccupancyCosts
2567 USD
CY2013Q4 us-gaap Occupancy Costs
OccupancyCosts
2783 USD
CY2014Q2 us-gaap Short Term Borrowings
ShortTermBorrowings
0 USD
CY2014Q2 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
272424 USD
CY2014Q4 us-gaap Notes Payable Current
NotesPayableCurrent
50000 USD
CY2014Q2 us-gaap Notes Payable Current
NotesPayableCurrent
33909 USD
CY2014Q4 us-gaap Deferred Compensation Liability Current
DeferredCompensationLiabilityCurrent
49640 USD
CY2014Q2 us-gaap Deferred Compensation Liability Current
DeferredCompensationLiabilityCurrent
0 USD
CY2014Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
4339 USD
CY2014Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
158244 USD
CY2014Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
15992 USD
CY2014Q4 ppch Loans From Related Party
LoansFromRelatedParty
35068 USD
CY2014Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
58315 USD
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1930189 USD
CY2014Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2014Q4 us-gaap Preferred Stock Value
PreferredStockValue
5000 USD
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
130775 USD
CY2014Q4 us-gaap Development Stage Enterprise Deficit Accumulated During Development Stage
DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage
18681696 USD
CY2014Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2014Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2014Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2014Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2014Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
500000 shares
CY2014Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2014Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2014Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
130774585 shares
CY2014Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
72684767 shares
CY2014Q4 us-gaap Royalty Revenue
RoyaltyRevenue
0 USD
us-gaap Royalty Revenue
RoyaltyRevenue
0 USD
CY2013Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
222671 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
475913 USD
us-gaap Occupancy Costs
OccupancyCosts
5344 USD
us-gaap Occupancy Costs
OccupancyCosts
5528 USD
CY2014Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2443 USD
CY2013Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
0 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6322 USD
CY2014Q4 us-gaap Operating Expenses
OperatingExpenses
249441 USD
CY2013Q4 us-gaap Operating Expenses
OperatingExpenses
225454 USD
us-gaap Operating Expenses
OperatingExpenses
487579 USD
us-gaap Operating Expenses
OperatingExpenses
534024 USD
CY2014Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-249441 USD
CY2013Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-225454 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-487579 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-534024 USD
CY2014Q4 us-gaap Interest Expense
InterestExpense
100176 USD
CY2013Q4 us-gaap Interest Expense
InterestExpense
20225 USD
us-gaap Interest Expense
InterestExpense
648655 USD
us-gaap Interest Expense
InterestExpense
22390 USD
CY2014Q4 us-gaap Investment Income Interest
InvestmentIncomeInterest
0 USD
CY2013Q4 us-gaap Investment Income Interest
InvestmentIncomeInterest
0 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
3 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
0 USD
CY2014Q4 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
0 USD
CY2013Q4 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
0 USD
us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
50002 USD
us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
0 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
0 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-723640 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-59539 USD
CY2014Q4 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
8206 USD
CY2013Q4 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
227616 USD
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
122742 USD
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-31634 USD
us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-182612 USD
us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-5515 USD
CY2014Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-178478 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-82440 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-48451 USD
us-gaap Net Income Loss
NetIncomeLoss
-1128779 USD
us-gaap Net Income Loss
NetIncomeLoss
-545112 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-910642 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-529944 USD
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
85827403 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
72014292 shares
CY2014Q4 us-gaap Gain Loss On Repurchase Of Debt Instrument
GainLossOnRepurchaseOfDebtInstrument
71147 USD
CY2013Q4 us-gaap Gain Loss On Repurchase Of Debt Instrument
GainLossOnRepurchaseOfDebtInstrument
0 USD
dei Document Type
DocumentType
10-Q
dei Amendment Flag
AmendmentFlag
false
dei Document Period End Date
DocumentPeriodEndDate
2014-12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2015
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Registrant Name
EntityRegistrantName
Propanc Health Group Corp
dei Entity Central Index Key
EntityCentralIndexKey
0001517681
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
dei Trading Symbol
TradingSymbol
PPCH
CY2015Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
191688405 shares
CY2014Q4 us-gaap Debt Instrument Periodic Payment
DebtInstrumentPeriodicPayment
4044 USD
us-gaap Use Of Estimates
UseOfEstimates
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt; BACKGROUND: transparent" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; BACKGROUND: transparent" align="justify"><u><font style="FONT-SIZE: 10pt">Use of Estimates</font></u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt; BACKGROUND: transparent" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; BACKGROUND: transparent" align="justify"><font style="FONT-SIZE: 10pt">The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period.&#160;&#160;Actual results could differ from these estimates.&#160;&#160;Significant estimates in the accompanying unaudited consolidated financial statements include the estimates of valuation of derivatives, valuation of beneficial conversion features on convertible debt, allowance for uncollectable receivables, valuation of equity based instruments issued for other than cash, the valuation allowance on deferred tax assets and foreign currency translation due to certain average exchange rates applied in lieu of spot rates on transaction dates.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
5621 USD
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
46585 USD
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
77861 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-271996 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-101820 USD
us-gaap Proceeds From Repayments Of Bank Overdrafts
ProceedsFromRepaymentsOfBankOverdrafts
0 USD
us-gaap Proceeds From Repayments Of Bank Overdrafts
ProceedsFromRepaymentsOfBankOverdrafts
-5 USD
ppch Related Party Expenses Paid On Behalf Of Company
RelatedPartyExpensesPaidOnBehalfOfCompany
0 USD
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
3915 USD
us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
218137 USD
ppch Write Off Of Capitalized Patent Costs
writeOffOfCapitalizedPatentCosts
27000 USD
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
112268 USD
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
237833 USD
ppch Loss On Settlement
LossOnSettlement
355000 USD
ppch Loss On Settlement
LossOnSettlement
0 USD
us-gaap Depreciation
Depreciation
0 USD
us-gaap Depreciation
Depreciation
523 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
117231 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
14789 USD
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-165428 USD
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
0 USD
ppch Increase Decrease In Gst Receivable
IncreaseDecreaseInGstReceivable
-1226 USD
ppch Increase Decrease In Gst Receivable
IncreaseDecreaseInGstReceivable
0 USD
us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
0 USD
us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
3345 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
46849 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
74120 USD
ppch Related Party Expenses Paid On Behalf Of Company
RelatedPartyExpensesPaidOnBehalfOfCompany
23937 USD
us-gaap Payments For Loans
PaymentsForLoans
20000 USD
us-gaap Payments For Loans
PaymentsForLoans
37032 USD
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
90000 USD
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
103959 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
99000 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
90859 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
99785 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
11697 USD
us-gaap Cash Period Increase Decrease
CashPeriodIncreaseDecrease
-73211 USD
us-gaap Cash Period Increase Decrease
CashPeriodIncreaseDecrease
736 USD
CY2014Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
87799 USD
CY2013Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0 USD
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14588 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
736 USD
us-gaap Interest Paid
InterestPaid
0 USD
us-gaap Interest Paid
InterestPaid
0 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
ppch Conversion Of Accrued Expenses To Common Stock
ConversionOfAccruedExpensesToCommonStock
0 USD
ppch Conversion Of Accrued Expenses To Common Stock
ConversionOfAccruedExpensesToCommonStock
27500 USD
ppch Conversion Of Convertible Notes And Accrued Interest To Common Stock
ConversionOfConvertibleNotesAndAccruedInterestToCommonStock
177567 USD
ppch Conversion Of Convertible Notes And Accrued Interest To Common Stock
ConversionOfConvertibleNotesAndAccruedInterestToCommonStock
0 USD
ppch Discounts Related To Warrants Issued With Convertible Debenture
DiscountsRelatedToWarrantsIssuedWithConvertibleDebenture
0 USD
ppch Discounts Related To Warrants Issued With Convertible Debenture
DiscountsRelatedToWarrantsIssuedWithConvertibleDebenture
133095 USD
ppch Discounts Related To Lender Costs
DiscountsRelatedToLenderCosts
33500 USD
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
18681696 USD
ppch Discounts Related To Lender Costs
DiscountsRelatedToLenderCosts
0 USD
CY2014Q3 us-gaap Debt Instrument Periodic Payment
DebtInstrumentPeriodicPayment
25000 USD
CY2014Q4 ppch Working Capital Deficit
WorkingCapitalDeficit
1877249 USD
ppch Conversion Of Loan Payable To Convertible Debenture
ConversionOfLoanPayableToConvertibleDebenture
0 USD
ppch Conversion Of Loan Payable To Convertible Debenture
ConversionOfLoanPayableToConvertibleDebenture
27963 USD
ppch Conversion Of Loan Payable To Common Stock
ConversionOfLoanPayableToCommonStock
66389 USD
ppch Conversion Of Loan Payable To Common Stock
ConversionOfLoanPayableToCommonStock
0 USD
ppch Issuance Of Preferred Stock For Services
IssuanceOfPreferredStockForServices
1067 USD
ppch Issuance Of Preferred Stock For Services
IssuanceOfPreferredStockForServices
0 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-100 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
0 USD
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
7308 USD
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
4256 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
0 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
0 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 USD
ppch Prepaid Common Stock Issued For Services
PrepaidCommonStockIssuedForServices
134373 USD
ppch Prepaid Common Stock Issued For Services
PrepaidCommonStockIssuedForServices
6667 USD
us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
37032 USD
us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
0 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
29000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
271996 USD
CY2014Q4 ppch Decrease In Liability Due To Director
DecreaseInLiabilityDueToDirector
44000 USD
ppch Settlement Fees Paid In Form Of Debt
SettlementFeesPaidInFormOfDebt
125000 USD
ppch Settlement Fees Paid In Form Of Debt
SettlementFeesPaidInFormOfDebt
0 USD
CY2014Q4 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
0.0011
CY2014Q4 us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
4870391 shares
CY2014Q3 us-gaap Payments For Fees
PaymentsForFees
50000 USD
CY2014Q3 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
50000 USD
CY2014Q4 us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
5655958 shares
CY2014Q4 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
4000000 shares
CY2014Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
3000000 shares
CY2014Q4 us-gaap Embedded Derivative Fair Value Of Embedded Derivative Liability
EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
49640 USD
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
4000000 shares
CY2014Q4 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
4339 USD
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
3000000 shares
CY2014Q4 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
33407 USD
CY2014Q2 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.1 pure
us-gaap Debt Instrument Periodic Payment
DebtInstrumentPeriodicPayment
25000 USD
us-gaap Debt Instrument Increase Accrued Interest
DebtInstrumentIncreaseAccruedInterest
1260 USD
CY2014Q4 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
0.008
CY2014Q4 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
0.0011
CY2014Q4 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
8161000 shares
CY2014Q4 us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
6698331 shares
CY2014Q4 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
5357 USD
CY2014Q4 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
7368 USD
CY2014Q4 us-gaap Debt Instrument Periodic Payment
DebtInstrumentPeriodicPayment
6000 USD
CY2014Q4 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
0.0012
CY2014Q4 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
0.0007
CY2014Q4 us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
5194805 shares
CY2014Q3 us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
7426000 shares
CY2014Q4 us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
8161000 shares
CY2014Q3 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments
StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
81396 USD
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments
StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
951422 USD
CY2013Q3 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
0.075
CY2014Q3 ppch Discounts Related To Warrants Issued With Convertible Debenture
DiscountsRelatedToWarrantsIssuedWithConvertibleDebenture
139680 USD
CY2014Q3 us-gaap Debt Instrument Increase Accrued Interest
DebtInstrumentIncreaseAccruedInterest
15118 USD
CY2014Q3 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
0.0709
CY2013Q3 us-gaap Accrued Rent Current And Noncurrent
AccruedRentCurrentAndNoncurrent
1000 USD
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
5344 USD
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
5528 USD
us-gaap Interest Expense Debt
InterestExpenseDebt
405000 USD
us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
15587000 shares
CY2014Q4 ppch Sale Of Stock Decreased Liability Owed To Purchaser
SaleOfStockDecreasedLiabilityOwedToPurchaser
52907 USD
CY2014Q2 us-gaap Derivative Liabilities
DerivativeLiabilities
158244 USD
us-gaap Gain Loss On Foreign Currency Fair Value Hedge Derivatives
GainLossOnForeignCurrencyFairValueHedgeDerivatives
32958 USD
ppch Fair Value Of Warrant Derivative Liability Recoreded As Debt Discount
FairValueOfWarrantDerivativeLiabilityRecorededAsDebtDiscount
27500 USD
ppch Fair Value Of Warrant Derivative Liability Recoreded As Change In Fair Value Of Eco
FairValueOfWarrantDerivativeLiabilityRecorededAsChangeInFairValueOfEco
23935 USD
us-gaap Embedded Derivative Gain Loss On Embedded Derivative Net
EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet
-122742 USD
CY2014Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
53979 USD
us-gaap Debt Instrument Convertible Threshold Percentage Of Stock Price Trigger
DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger
0.12 pure
CY2014Q3 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
139680 USD
CY2014Q3 us-gaap Debt Instrument Periodic Payment
DebtInstrumentPeriodicPayment
154798 USD
CY2014Q3 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
0.0709
CY2014Q3 us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
2183333 shares
CY2013Q3 us-gaap Fair Value Assumptions Expected Term
FairValueAssumptionsExpectedTerm
P27M
CY2014Q3 us-gaap Debt Instrument Maturity Date Description
DebtInstrumentMaturityDateDescription
two years
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
50000 USD
us-gaap Debt Conversion Description
DebtConversionDescription
convertible note that was issued on May 30, 2014 and has the same terms
us-gaap Debt Conversion Original Debt Issuance Date Of Debt Day Month And Year
DebtConversionOriginalDebtIssuanceDateOfDebtDayMonthAndYear
2014-05-30
CY2014Q4 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
10000000 shares
CY2014Q4 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
80000 USD
CY2014Q2 us-gaap Debt Instrument Convertible Terms Of Conversion Feature
DebtInstrumentConvertibleTermsOfConversionFeature
The note is convertible immediately at 50% of the lowest closing bid price in the 30 trading days prior to conversion.
CY2014Q3 us-gaap Debt Instrument Unamortized Premium
DebtInstrumentUnamortizedPremium
355000 USD
CY2014Q3 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
628000 USD
CY2014Q4 us-gaap Convertible Debt
ConvertibleDebt
25000 USD
CY2014Q4 us-gaap Share Price
SharePrice
0.0015
CY2013Q3 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
0.075
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2014Q4 us-gaap Fees And Commissions Transfer Agent
FeesAndCommissionsTransferAgent
7779 USD
CY2014Q4 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
2500 USD
CY2014Q4 us-gaap Legal Fees
LegalFees
5000 USD
CY2014Q4 us-gaap Proceeds From Sale Of Notes Receivable
ProceedsFromSaleOfNotesReceivable
34721 USD
CY2014Q3 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
2500 USD

Files In Submission

Name View Source Status
0001144204-15-009533-index-headers.html Edgar Link pending
0001144204-15-009533-index.html Edgar Link pending
0001144204-15-009533.txt Edgar Link pending
0001144204-15-009533-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
ppch-20141231.xml Edgar Link completed
ppch-20141231.xsd Edgar Link pending
ppch-20141231_cal.xml Edgar Link unprocessable
ppch-20141231_def.xml Edgar Link unprocessable
ppch-20141231_lab.xml Edgar Link unprocessable
ppch-20141231_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v401132_10q.htm Edgar Link pending
v401132_ex10-5.htm Edgar Link pending
v401132_ex10-6.htm Edgar Link pending
v401132_ex31-1.htm Edgar Link pending
v401132_ex31-2.htm Edgar Link pending
v401132_ex32-1.htm Edgar Link pending
v401132_ex32-2.htm Edgar Link pending